Medicinal Products

3219. Deputy Richard Boyd Barrett asked the Minister for Health the reason certain items (details supplied) have been delisted from the drug payment scheme; if she will consider the financial impact this causes for those who are on low incomes but are ineligible for a full medical card, and often have to pay the full €80 DPS limit; and if she will make a statement on the matter. [55259/26]

3239. Deputy Jen Cummins asked the Minister for Health her plans for patients to access belzutifan (welireg) for patients living with von hippel-lindau disease in Ireland. [55391/26]

3305. Deputy Barry Ward asked the Minister for Health the position regarding negotiations ongoing in relation to the approval for reimbursement status of a drug (details supplied), which is used as part of the wider treatment of some cancers; and if she will make a statement on the matter. [55769/26]

3306. Deputy Barry Ward asked the Minister for Health the action she will take to engage with the HSE to expedite delays in relation to the approval for reimbursement status of a drug (details supplied) which is used as part of the wider treatment of some cancers; and if she will make a statement on the matter. [55770/26]

3307. Deputy Barry Ward asked the Minister for Health if she will consider facilitating a meeting with a person diagnosed with cancer and their supporters in relation to adding a cancer treatment to the list of approved drugs for reimbursement (details supplied); and if she will make a statement on the matter. [55771/26]

3308. Deputy Barry Ward asked the Minister for Health the reason that a drug used in the treatment of cancer (details supplied) is not available for reimbursement status for patients in Ireland in spite of its widespread use in the EU and approval for use by the European Medicines Agency; and if she will make a statement on the matter. [55772/26]

3309. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to a detailed submission in relation to adding a cancer treatment to the list of approved drugs for reimbursement (details supplied); and if she will make a statement on the matter. [55773/26]

3310. Deputy John Lahart asked the Minister for Health the position regarding the establishment of an early access scheme for orphan medicines; and if she will make a statement on the matter. [55774/26]

3331. Deputy Pádraig Rice asked the Minister for Health if there are any plans to fund biological drugs for the treatment of lupus; the status of two applications (details supplied); and if she will make a statement on the matter. [55812/26]

3359. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the case of a person (details supplied); the steps she will take to ensure that they have access to the level of treatment required; and if she will make a statement on the matter. [56012/26]

3631. Deputy Pádraig Rice asked the Minister for Health if she will meet with an organisation (details supplied) regarding implementing an early access scheme; and if she will make a statement on the matter. [57126/26]

3683. Deputy Pádraig Rice asked the Minister for Health the status of a drug reimbursement application (details supplied); the timeline being worked towards for a decision; and if she will make a statement on the matter. [57384/26]

3722. Deputy Paula Butterly asked the Minister for Health to respond to correspondence received (details supplied) in relation to EU proposals regarding vitamin and mineral supplements; and if she will make a statement on the matter. [57469/26]

3872. Deputy Pádraig Rice asked the Minister for Health further to Parliamentary Question No. 290 of 27 May 2026, to provide an update on the development of a sandboxed early access programme for rare diseases; if there has been any progress or developments since May; the timeline she is working towards; and if she will make a statement on the matter. [58074/26]

4069. Deputy Rory Hearne asked the Minister for Health to outline the progress her Department has made in reducing the turnaround for reimbursement decisions for orphan drugs; and if she will make a statement on the matter. [59085/26]

4070. Deputy Rory Hearne asked the Minister for Health to provide an update on development of a pathway to timely orphan drug approval; and if she will make a statement on the matter. [59086/26]

4071. Deputy Rory Hearne asked the Minister for Health the steps being taken by her Department to make belzutifan available to patients with von Hippel-Lindau disease; and if she will make a statement on the matter. [59087/26]

4094. Deputy Carol Nolan asked the Minister for Health to provide an update on the status of the HSE assessment of the application for pricing and reimbursement of belzutifan (welireg) (details supplied); to outline the current stage of the application within the HSE's formal assessment and approval processes, including the engagement that has taken place with the applicant; to provide an indicati…

565. Deputy Jennifer Whitmore asked the Minister for Health if there are pathways for women using trial drugs to treat adenomyosis to have their costs fully or partially covered by the State; and if she will make a statement on the matter. [54676/26]

368. Deputy Pádraig O'Sullivan asked the Minister for Health the steps being taken to address the shortage of bumetanide, which has been in short supply since early May 2026 with an expected return date of the end of the year; the interim arrangements in place to protect patients with heart failure who depend on this medicine; and if she will make a statement on the matter. [53753/26]

369. Deputy Pádraig O'Sullivan asked the Minister for Health whether she will bring forward legislative proposals to permit therapeutic substitution by pharmacists during medicine shortages; and if she will make a statement on the matter. [53754/26]

381. Deputy Niamh Smyth asked the Minister for Health if she will provide an update on the HSE's consideration of Skyclarys for the treatment of Friedreich's ataxia; the reason the drug was not included on the agenda of the HSE Drugs Group meeting of 14 July 2026; if she will confirm when a decision is expected; and if she will make a statement on the matter. [53801/26]

400. Deputy Colm Burke asked the Minister for Health to confirm whether nirsevimab, the RSV vaccine, will be made available by the HSE for newborn babies from September 2026; and if she will make a statement on the matter. [53924/26]

699. Deputy Eoin Ó Broin asked the Minister for Health if she will confirm that Skyclarys will be on the agenda for the upcoming HSE Drugs Group meeting in July; and if she will make a statement on the matter. [52634/26]

748. Deputy Claire Kerrane asked the Minister for Health the reason a drug (details supplied) is not accessible in Ireland to cancer patients despite approval by the European Medicines Agency and its accessibility in many other parts of the EU and in the North of Ireland, if she will examine this and make the drug available for cancer patients where their oncology team has recommended it; and if s…